The Human Cytomegalovirus UL97 Protein Kinase, an Antiviral Drug Target, Is Required at the Stage of Nuclear Egress
Human cytomegalovirus encodes an unusual protein kinase, UL97, that activates the established antiviral drug ganciclovir and is specifically inhibited by a new antiviral drug, maribavir. We used maribavir and a UL97 null mutant, which is severely deficient in viral replication, to determine what sta...
Salvato in:
| Pubblicato in: | J Virol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
2003
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140798/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12502806/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.2.905-914.2003 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|